L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own APLS

Apellis Pharmaceuticals Inc in the Q2 2026 filings. None of the 91 current managers lists it among its largest positions this quarter. What is here is what they held before selling out.

Managers holding
0
at least, of 91 current
Combined value
$0
as reported
Opened
0
new this quarter
Added to
0
already held
Trimmed or sold out
30
30 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Sold out of this quarter

Valued at what the position was worth in the previous filing, because by this one it is gone.

Ownership through time

At least 15 of the 95 managers whose filings are on file listed APLS in Q1 2026, against 3 in Q1 2019. 10 managers more than in Q4 2025: 4 started positions; 7 listed it again; 1 no longer listed it among the positions read, which can mean a holding below the listed range, a filing that reported no holdings, or a filing not yet made.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
0815Q1 2019: 319Q2 2019: 4Q3 2019: 3Q4 2019: 5Q1 2020: 820Q2 2020: 8Q3 2020: 5Q4 2020: 5Q1 2021: 521Q2 2021: 6Q3 2021: 5Q4 2021: 6Q1 2022: 422Q2 2022: 5Q3 2022: 10Q4 2022: 8Q1 2023: 1223Q2 2023: 14Q3 2023: 3Q4 2023: 5Q1 2024: 824Q2 2024: 6Q3 2024: 5Q4 2024: 6Q1 2025: 525Q2 2025: 6Q3 2025: 7Q4 2025: 5Q1 2026: 1526
  • Q1 2019: 3
  • Q2 2019: 4
  • Q3 2019: 3
  • Q4 2019: 5
  • Q1 2020: 8
  • Q2 2020: 8
  • Q3 2020: 5
  • Q4 2020: 5
  • Q1 2021: 5
  • Q2 2021: 6
  • Q3 2021: 5
  • Q4 2021: 6
  • Q1 2022: 4
  • Q2 2022: 5
  • Q3 2022: 10
  • Q4 2022: 8
  • Q1 2023: 12
  • Q2 2023: 14
  • Q3 2023: 3
  • Q4 2023: 5
  • Q1 2024: 8
  • Q2 2024: 6
  • Q3 2024: 5
  • Q4 2024: 6
  • Q1 2025: 5
  • Q2 2025: 6
  • Q3 2025: 7
  • Q4 2025: 5
  • Q1 2026: 15
Their combined reported value
$0$1bn$2bnQ1 2019: $39m19Q2 2019: $193mQ3 2019: $67mQ4 2019: $155mQ1 2020: $419m20Q2 2020: $516mQ3 2020: $424mQ4 2020: $786mQ1 2021: $591m21Q2 2021: $1.2bnQ3 2021: $404mQ4 2021: $850mQ1 2022: $1.2bn22Q2 2022: $979mQ3 2022: $1.1bnQ4 2022: $851mQ1 2023: $1.4bn23Q2 2023: $2.1bnQ3 2023: $587mQ4 2023: $1.1bnQ1 2024: $1.0bn24Q2 2024: $670mQ3 2024: $490mQ4 2024: $498mQ1 2025: $390m25Q2 2025: $326mQ3 2025: $362mQ4 2025: $366mQ1 2026: $630m26
  • Q1 2019: $39m
  • Q2 2019: $193m
  • Q3 2019: $67m
  • Q4 2019: $155m
  • Q1 2020: $419m
  • Q2 2020: $516m
  • Q3 2020: $424m
  • Q4 2020: $786m
  • Q1 2021: $591m
  • Q2 2021: $1.2bn
  • Q3 2021: $404m
  • Q4 2021: $850m
  • Q1 2022: $1.2bn
  • Q2 2022: $979m
  • Q3 2022: $1.1bn
  • Q4 2022: $851m
  • Q1 2023: $1.4bn
  • Q2 2023: $2.1bn
  • Q3 2023: $587m
  • Q4 2023: $1.1bn
  • Q1 2024: $1.0bn
  • Q2 2024: $670m
  • Q3 2024: $490m
  • Q4 2024: $498m
  • Q1 2025: $390m
  • Q2 2025: $326m
  • Q3 2025: $362m
  • Q4 2025: $366m
  • Q1 2026: $630m

Between the quarter ends of Q4 2025 and Q1 2026. Each change in shares is valued at the Q1 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Largest increases, by shares

Largest decreases, by shares

Left it

No manager on file is shown leaving it.

ManagerValue over timeFirst listedLargestQ1 2026
Point72 Asset Management LPQ2 2019$168m$168m
Millennium Management LLCQ1 2019$91m$91m
Balyasny Asset Management LLCQ1 2023$77m$77m
Hudson Bay Capital Management LPQ3 2020$48m$48m
Soros Fund Management LLCQ1 2024$42m$42m
Woodline Partners LPQ4 2019$39m$39m
Renaissance Technologies LLCQ1 2026$38m$38m
Marshall Wace LLPQ1 2022$62m$37m
Man Group PLCQ2 2020$37m$37m
Tudor Investment CorpQ4 2020$26m$26m
Verition Fund Management LLCQ1 2020$16m$16m
Schonfeld Strategic Advisors LLCQ4 2019$15m$5.0m
Winton Group LtdQ4 2025$2.8m$2.8m
PDT Partners LLCQ1 2019$4.4m$2.2m
Farallon Capital Management LLCQ4 2019$130m$241k
Wellington Management Group LLPQ2 2019$984mlast listed Q4 2025
T. Rowe Price Associates IncQ2 2021$644mlast listed Q1 2024
Fidelity (FMR LLC)Q2 2023$385mlast listed Q2 2023
Janus Henderson Group LtdQ4 2022$309mlast listed Q2 2023
AQR Capital Management LLCQ4 2024$103mlast listed Q3 2025
Viking Global Investors LPQ3 2022$64mlast listed Q3 2022
D. E. Shaw & Co.Q2 2023$48mlast listed Q2 2023
Two Sigma Advisers LPQ1 2020$41mlast listed Q3 2021
Two Sigma Investments LPQ1 2020$30mlast listed Q2 2021
Voloridge Investment Management LLCQ2 2021$26mlast listed Q3 2025

What APLS is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around APLS →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.